J. G. Giri, IL-15, a novel T cell growth factor that shares activities and receptor components with IL-2, J Leukoc Biol, vol.57, issue.5, pp.763-766, 1995.

J. G. Giri, Identification and cloning of a novel IL-15 binding protein that is structurally related to the ? chain of the IL-2 receptor, EMBO J, vol.14, issue.15, pp.3654-3663, 1995.

S. Dubois, J. Mariner, T. A. Waldmann, and Y. Tagaya, IL-15Ralpha recycles and presents IL-15 In trans to neighboring cells, Immunity, vol.17, issue.5, pp.537-547, 2002.

P. R. Burkett, Coordinate expression and trans presentation of interleukin (IL)-15Ralpha and IL-15 supports natural killer cell and memory CD8+ T cell homeostasis, J Exp Med, vol.200, issue.7, pp.825-834, 2004.

E. Mortier, Macrophage-and dendritic-cell-derived interleukin-15 receptor alpha supports homeostasis of distinct CD8+ T cell subsets, Immunity, vol.31, issue.5, pp.811-822, 2009.

E. Mortier, T. Woo, R. Advincula, S. Gozalo, and A. Ma, IL-15Ralpha chaperones IL-15 to stable dendritic cell membrane complexes that activate NK cells via trans presentation, J Exp Med, vol.205, issue.5, pp.1213-1225, 2008.

E. Mortier, J. Bernard, A. Plet, and Y. Jacques, Natural, proteolytic release of a soluble form of human IL-15 receptor alpha-chain that behaves as a specific, high affinity IL-15 antagonist, J Immunol, vol.173, issue.3, pp.1681-1688, 2004.

E. Mortier, Soluble interleukin-15 receptor alpha (IL-15R alpha)-sushi as a selective and potent agonist of IL-15 action through IL-15R beta/gamma. Hyperagonist IL-15 x IL-15R alpha fusion proteins, J Biol Chem, vol.281, issue.3, pp.1612-1619, 2006.

M. P. Rubinstein, Converting IL-15 to a superagonist by binding to soluble IL-15Ralpha, Proc Natl Acad Sci, vol.103, issue.24, pp.9166-9171, 2006.

T. A. Stoklasek, K. S. Schluns, and L. Lefrançois, Combined IL-15/IL-15Ralpha immunotherapy maximizes IL-15 activity in vivo, J Immunol, vol.177, issue.9, pp.6072-6080, 2006.

J. R. Müller, T. A. Waldmann, M. J. Kruhlak, and S. Dubois, Paracrine and transpresentation functions of IL-15 are mediated by diverse splice versions of IL-15R? in human monocytes and dendritic cells, J Biol Chem, vol.287, issue.48, pp.40328-40338, 2012.

Y. Rochman, R. Spolski, and W. J. Leonard, New insights into the regulation of T cells by ?(c) family cytokines, Nat Rev Immunol, vol.9, issue.7, pp.480-490, 2009.

J. Müllberg, The soluble human IL-6 receptor. Mutational characterization of the proteolytic cleavage site, J Immunol, vol.152, issue.10, pp.4958-4968, 1994.

E. Chertova, Characterization and favorable in vivo properties of heterodimeric soluble IL-15·IL-15R? cytokine compared to IL-15 monomer, J Biol Chem, vol.288, issue.25, pp.18093-18103, 2013.

I. Lorenzen, The membrane-proximal domain of A Disintegrin and Metalloprotease 17 (ADAM17) is responsible for recognition of the interleukin-6 receptor and interleukin-1 receptor II, FEBS Lett, vol.586, issue.8, pp.1093-1100, 2012.

R. Barreira-da-silva, C. Graf, and C. Münz, Cytoskeletal stabilization of inhibitory interactions in immunologic synapses of mature human dendritic cells with natural killer cells, Blood, vol.118, issue.25, pp.6487-6498, 2011.

F. Brilot, T. Strowig, S. M. Roberts, F. Arrey, and C. Münz, NK cell survival mediated through the regulatory synapse with human DCs requires IL-15Ralpha, J Clin Invest, vol.117, issue.11, pp.3316-3329, 2007.

P. Lehours, Subunit structure of the high and low affinity human interleukin-15 receptors, Eur Cytokine Netw, vol.11, issue.2, pp.207-215, 2000.

M. Rickert, X. Wang, M. J. Boulanger, N. Goriatcheva, and K. C. Garcia, The structure of interleukin-2 complexed with its alpha receptor, Science, vol.308, issue.5727, pp.1477-1480, 2005.

X. Wang, M. Rickert, and K. C. Garcia, Structure of the quaternary complex of interleukin-2 with its alpha, beta, and gammac receptors, Science, vol.310, issue.5751, pp.1159-1163, 2005.

A. M. Ring, Mechanistic and structural insight into the functional dichotomy between IL-2 and IL-15, Nat Immunol, vol.13, issue.12, pp.1187-1195, 2012.

H. Perdreau, Different dynamics of IL-15R activation following IL-15 cis-or trans-presentation, Eur Cytokine Netw, vol.21, issue.4, pp.297-307, 2010.
URL : https://hal.archives-ouvertes.fr/inserm-02437096

H. Beuneu, Dynamic behavior of NK cells during activation in lymph nodes, Blood, vol.114, issue.15, pp.3227-3234, 2009.

T. A. Fehniger, Fatal leukemia in interleukin 15 transgenic mice follows early expansions in natural killer and memory phenotype CD8+ T cells, J Exp Med, vol.193, issue.2, pp.219-231, 2001.

J. D. Burton, A lymphokine, provisionally designated interleukin T and produced by a human adult T-cell leukemia line, stimulates T-cell proliferation and the induction of lymphokine-activated killer cells, Proc Natl Acad Sci, vol.91, issue.11, pp.4935-4939, 1994.

N. Azimi, Human T cell lymphotropic virus type I Tax protein trans-activates interleukin 15 gene transcription through an NF-kappaB site, Proc Natl Acad Sci, vol.95, issue.5, pp.2452-2457, 1998.

N. Azimi, S. Jacobson, T. Leist, and T. A. Waldmann, Involvement of IL-15 in the pathogenesis of human T lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis: Implications for therapy with a monoclonal antibody directed to the IL-2/ 15R beta receptor, J Immunol, vol.163, issue.7, pp.4064-4072, 1999.

N. Sato, Development of an IL-15-autocrine CD8 T-cell leukemia in IL-15-transgenic mice requires the cis expression of IL-15R?, Blood, vol.117, issue.15, pp.4032-4040, 2011.

T. Kukita, Autocrine and/or paracrine growth of adult T-cell leukaemia tumour cells by interleukin 15, Br J Haematol, vol.119, issue.2, pp.467-474, 2002.

I. Tinhofer, I. Marschitz, T. Henn, A. Egle, and R. Greil, Expression of functional interleukin-15 receptor and autocrine production of interleukin-15 as mechanisms of tumor propagation in multiple myeloma, Blood, vol.95, issue.2, pp.610-618, 2000.

J. Chen, Increased serum soluble IL-15R? levels in T-cell large granular lymphocyte leukemia, Blood, vol.119, issue.1, pp.137-143, 2012.

B. Kaluza, G. Betzl, H. Shao, T. Diamantstein, and U. H. Weidle, A general method for chimerization of monoclonal antibodies by inverse polymerase chain reaction which conserves authentic N-terminal sequences, Gene, vol.122, issue.2, pp.321-328, 1992.